 The aim of the present study was to report experiences with invasive prenatal diagnosis of α-thalassemia for the prevention of Hb Bart 's hydrops fetalis syndrome<symptom> in the Guangxi Zhuang Autonomous Region , China. Pregnant women and their partners who tested positive for α An invasive prenatal α-thalassemia diagnosis was performed in 3155 cases at risk for Hb Bart 's hydrops fetalis syndrome<symptom> at our hospital from 2002 to 2016. CVS was performed in 1559 cases ( 49.4 %) , amniocentesis in 1240 cases ( 39.3 %) and cordocentesis in 356 cases ( 11.3 %). In total , 786 fetuses were diagnosed as Hb Bart 's hydrops fetalis syndrome<symptom>. Among these cases , the α-thalassemia genotype was-- This extensive experience suggests that carrier screening , molecular diagnostics , genetic counselling , and prenatal diagnosis are effective measures to prevent Hb Bart 's hydrops fetalis syndrome<symptom>.